© 2021 KALW
KALW Public Media / 91.7 FM Bay Area
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
News

FDA approves Pfizer’s Covid vaccine for children five to 11 years old

vaccinesnationalguard.jpg
Christian Emmer
/
Flickr / Creative Commons
Medical worker is about to administer a vaccination into child's arm

Now that the FDA gave its emergency approval of the vaccine for younger children, the Centers for Disease Control and Prevention will hold a final review on November 2nd and 3rd.

In an interview with Mission Local, UCSF researchers explain the 2021 Pfizer trial of nearly 4,500 children, ranging from ages five to 11, had an efficacy rate of 91 percent.

A UCSF professor and epidemiologist notes that the vaccine seems to be safe at this age range and has not shown any adverse effects. She explains a smaller sample size may not show more rare events, such as heart muscle inflammation. 

If the CDC approves the vaccine for the younger demographic, UCSF researchers expect the vaccines to start rolling out by mid-November.

Last month, the San Francisco Department of Public Health announced plans to prioritize vaccinations for children under 12 at their nearly 100 pre-existing vaccination sites.